Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease

Show other versions (2)

Bibliographic Details
Main Authors:	Wilcock, G, Whitehead, A, Evans, J, Birks, J, Perdomo, C, Pratt, R
Format:	Journal article
Published:	2001

Similar Items

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Pratt, R, et al.
Published: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Perdomo, C, et al.
Published: (2003)

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
by: Whitehead, A, et al.
Published: (2004)

Donepezil for dementia due to Alzheimer's disease
by: Birks, J, et al.
Published: (2018)

The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials.
by: Wilcock, G, et al.
Published: (2002)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
by: Howard, R, et al.
Published: (2012)

Intepirdine as adjunctive therapy to donepezil for mild‐to‐moderate Alzheimer's disease: A randomized, placebo‐controlled, phase 3 clinical trial (MINDSET)
by: Frederick M. Lang, et al.
Published: (2021-01-01)

Donepezil for the treatment of agitation in Alzheimer's disease.
by: Howard, R, et al.
Published: (2007)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
by: Wilcock, G, et al.
Published: (2003)

Donepezil for vascular cognitive impairment
by: Malouf, R, et al.
Published: (2004)

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
by: Zou Heng, et al.
Published: (2011-05-01)

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
by: Pirttilä, T, et al.
Published: (2004)

Personalized prediction of Alzheimer's disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials
by: Yoshida, K, et al.
Published: (2022)

Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials
by: Abdelrahman Ibrahim Abushouk, et al.
Published: (2017-04-01)

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
by: Wilcock, G, et al.
Published: (2003)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (vol 321, pg 1445, 2000)
by: Wilcock, G
Published: (2001)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
by: Jones, R, et al.
Published: (2009)

Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
by: Griffanti, L, et al.
Published: (2016)

The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer’s disease
by: Martin Valis, et al.
Published: (2023-03-01)

Evidence-based pharmacotherapy of Alzheimer's disease.
by: Evans, J, et al.
Published: (2004)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
by: Wilcock, G, et al.
Published: (2000)

Galantamine vs donepezil in the treatment of Alzheimer's disease.
by: Goldlist, B, et al.
Published: (2003)

Peran donepezil dalam terapi penyakit alzheimer
by: Perpustakaan UGM, i-lib
Published: (1999)

Delirium Associated with Donepezil in a Patient with Alzheimer’s Disease: a Case Report
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01)

Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil
by: Levine, SZ, et al.
Published: (2022)

Differential response to donepezil in MRI subtypes of mild cognitive impairment
by: Patricia Diaz-Galvan, et al.
Published: (2023-06-01)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9) (1445-1449))
by: Wilcock, G
Published: (2001)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9)(1445-1449))
by: Wilcock, G
Published: (2001)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
by: Yoshiyuki Kagawa, et al.
Published: (2021-12-01)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
by: Howard, R, et al.
Published: (2012)

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment
by: Patricia Diaz‑Galvan, et al.
Published: (2023-10-01)

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
by: Wilcock, G, et al.
Published: (2008)

A systematic review of economic evaluations of the use of memantine alone or combined with donepezil for moderate to severe Alzheimer’s disease
by: Ione Ayala Gualandi de Oliveira, et al.
Published: (2019-11-01)

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
by: Deardorff WJ, et al.
Published: (2016-10-01)

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
by: Green, R, et al.
Published: (2009)

Corrigendum to “The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer’s disease” [Biomed. Pharmacother. 159 (2023) 114223]
by: Martin Valis, et al.
Published: (2023-09-01)

Efficacy and Safety of Woohwangchungsimwon Combined with Donepezil in Behavioral and Psychological Symptoms of Dementia in Patients with Probable Alzheimer’s Disease: Study Protocol for a Randomized Controlled Trial
by: Man Gi Kim, et al.
Published: (2023-07-01)

The clinical efficacy of Olibanum gum chewing in patients with Mild‐to‐Moderate Alzheimer disease: A randomized Parallel‐Design controlled trial
by: Fereshteh Ghorat, et al.
Published: (2024-03-01)

Analysis of word number and content in discourse of patients with mild to moderate Alzheimer's disease
by: Juliana Onofre de Lira, et al.